Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK
Pancuronium Bromide 2 mg/ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear, colourless solution. |
Each 1 ml contains 2 mg of pancuronium bromide. Each ml also contains 0.15 mmol sodium.
Each 2 ml ampoule contains 4 mg of pancuronium bromide. Each 2 ml ampoule also contains 0.3 mmol sodium.
Excipient(s) with known effect: This medicinal product contains sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Pancuronium |
Pancuronium produces pharmacologic effects similar to those of other non-depolarising neuromuscular blocking agents. The drug may produce an increase in heart rate which appears to result from a direct blocking effect on the acetylcholine receptors of the heart. Pancuronium causes little or no histamine release and no ganglionic blockade and therefore does not cause hypotension or bronchospasm. |
| List of Excipients |
|---|
|
Sodium chloride |
2ml Type I clear glass ampoules.
Pack sizes of 5, 10 and 50.
Not all pack sizes may be marketed.
Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK
PL 04515/0062
Date of first authorisation: 07/02/1997
Date of last renewal: 12/02/2003
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
